The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel with or without bevacizumab as second-line therapy or beyond for patients with metastatic non-small-cell lung cancer.
 
Fan Zhang
No Relationships to Disclose
 
Tao Li
No Relationships to Disclose
 
Yuzi Zhang
Employment - 3D Medicines
 
Shangli Cai
Employment - 3D Medicines
 
Lei Zhao
No Relationships to Disclose
 
Shun Chang Jiao
No Relationships to Disclose
 
Yi Hu
No Relationships to Disclose